Literature DB >> 32282993

DOACs and "newer" hemophilia therapies in COVID-19: Reply.

Jecko Thachil1, Ning Tang2, Satoshi Gando3, Anna Falanga4,5, Marco Cattaneo6, Marcel Levi7, Cary Clark8, Toshiaki Iba9.   

Abstract

Entities:  

Keywords:  COVID-19; anticoagulant; thrombosis

Mesh:

Year:  2020        PMID: 32282993     DOI: 10.1111/jth.14841

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  10 in total

1.  The role of direct oral anticoagulants in the era of COVID-19: are antiviral therapy and pharmacogenetics limiting factors?

Authors:  Hrvoje Roguljić; Jerko Arambašić; Vjera Ninčević; Lucija Kuna; Igor Šesto; Ashraf Tabll; Robert Smolić; Aleksandar Včev; Dragan Primorac; George Y Wu; Martina Smolić
Journal:  Croat Med J       Date:  2022-06-22       Impact factor: 2.415

Review 2.  Anticoagulation Options for Coronavirus Disease 2019 (COVID-19)-Induced Coagulopathy.

Authors:  Alla Turshudzhyan
Journal:  Cureus       Date:  2020-05-16

Review 3.  COVID-19 Pandemic: Cardiovascular Complications and Future Implications.

Authors:  Dhrubajyoti Bandyopadhyay; Tauseef Akhtar; Adrija Hajra; Manasvi Gupta; Avash Das; Sandipan Chakraborty; Ipsita Pal; Neelkumar Patel; Birendra Amgai; Raktim K Ghosh; Gregg C Fonarow; Carl J Lavie; Srihari S Naidu
Journal:  Am J Cardiovasc Drugs       Date:  2020-08       Impact factor: 3.571

Review 4.  COVID‑19 and ischemic stroke: Mechanisms of hypercoagulability (Review).

Authors:  Shuoqi Zhang; Jinming Zhang; Chunxu Wang; Xiaojing Chen; Xinyi Zhao; Haijiao Jing; Huan Liu; Zhuxin Li; Lihua Wang; Jialan Shi
Journal:  Int J Mol Med       Date:  2021-01-15       Impact factor: 4.101

Review 5.  COVID-19-related coagulopathy: A review of pathophysiology and pharmaceutical management.

Authors:  Mahdi Kohansal Vajari; Mahsa Shirin; Atieh Pourbagheri-Sigaroodi; Mohammad Esmaeil Akbari; Hassan Abolghasemi; Davood Bashash
Journal:  Cell Biol Int       Date:  2021-05-16       Impact factor: 4.473

Review 6.  Is the Endothelium the Missing Link in the Pathophysiology and Treatment of COVID-19 Complications?

Authors:  Pedro Castro; Marta Palomo; Ana Belen Moreno-Castaño; Sara Fernández; Sergi Torramadé-Moix; Georgina Pascual; Julia Martinez-Sanchez; Edward Richardson; Adrián Téllez; Josep M Nicolas; Enric Carreras; Paul G Richardson; Juan José Badimon; Gines Escolar; Maribel Diaz-Ricart
Journal:  Cardiovasc Drugs Ther       Date:  2021-06-07       Impact factor: 3.947

Review 7.  The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management.

Authors:  Mouhamed Yazan Abou-Ismail; Akiva Diamond; Sargam Kapoor; Yasmin Arafah; Lalitha Nayak
Journal:  Thromb Res       Date:  2020-06-20       Impact factor: 3.944

Review 8.  Management of Thrombotic Complications in COVID-19: An Update.

Authors:  Adrija Hajra; Sheetal Vasundara Mathai; Somedeb Ball; Dhrubajyoti Bandyopadhyay; Maedeh Veyseh; Sandipan Chakraborty; Carl J Lavie; Wilbert S Aronow
Journal:  Drugs       Date:  2020-10       Impact factor: 9.546

Review 9.  COVID-19 and Venous Thromboembolism: From Pathological Mechanisms to Clinical Management.

Authors:  Xianghui Zhou; Zhipeng Cheng; Yu Hu
Journal:  J Pers Med       Date:  2021-12-08

10.  Anticoagulation Prior to COVID-19 Infection Has No Impact on 6 Months Mortality: A Propensity Score-Matched Cohort Study.

Authors:  Marcin Protasiewicz; Konrad Reszka; Wojciech Kosowski; Barbara Adamik; Wojciech Bombala; Adrian Doroszko; Damian Gajecki; Jakub Gawryś; Maciej Guziński; Maria Jedrzejczyk; Krzysztof Kaliszewski; Katarzyna Kilis-Pstrusinska; Bogusława Konopska; Agnieszka Kopec; Krzysztof Kujawa; Anna Langner; Anna Larysz; Weronika Lis; Lilla Pawlik-Sobecka; Joanna Gorka-Dynysiewicz; Marta Rosiek-Biegus; Agnieszka Matera-Witkiewicz; Tomasz Matys; Michał Pomorski; Mateusz Sokolski; Janusz Sokołowski; Anna Tomasiewicz-Zapolska; Katarzyna Madziarska; Ewa A Jankowska
Journal:  J Clin Med       Date:  2022-01-12       Impact factor: 4.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.